Mazur et al (2014) showed that SMYD3 methylation of MAP3K2 leads to upregulation of MAP kinase signaling and promotes carcinogenesis in RAS mutated lung and pancreatic cancers. Here, MAP3K2 is linked to pancreatic neoplasm.